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Aim. To determine trace element status and aetiologic factors for development of trace elements deficiencies in children with iron-
deficiency anaemia (IDA) aged 0 to 3 years. Contingent and Methods. 30 patients of the University Hospital, Pleven, Bulgaria—I
group; 48 patients of the Sumy Regional Child’s Clinical Hospital, Sumy, Ukraine—II group; 25 healthy controls were investigated.
Serum concentrations of iron, zinc, copper, chromium, cobalt, and nickel were determined spectrophotometrically and by atomic
absorption spectrophotometry. Results. Because the obtained serum levels of zinc, copper, and chromium were near the lower
reference limits, I group was divided into IA and IB. In IA group, serum concentrations were lower than the reference values for
47%, 57%, and 73% of patients, respectively. In IB group, these were within the reference values. In II group, results for zinc, cobalt,
and nickel were significantly lower (𝑃 < 0.05), and results for copper were significantly higher in comparison to controls higher in
comparison to controls. Conclusion. Low serum concentrations of zinc, copper, cobalt, and nickel were mainly due to inadequate
dietary intake, malabsorption, and micronutrient interactions in both studied groups. Increased serum copper in II group was
probably due to metabolic changes resulting from adaptations in IDA. Data can be used for developing a diagnostic algorithm for
IDA.
1. Introduction
Under conditions of iron-deficiency anaemia (IDA), a host
of metabolic changes representing adaptation mechanisms
for maximizing iron delivery for erythropoiesis occur [1, 2].
There are close relations between the metabolism of different
trace elements including iron based on antagonistic or
synergistic interactions [3, 4]. One of known links is at the
level of common intestinal transporters for iron and other
divalent metals. Upregulation of their expression induced by
iron deficiency (ID) predisposes tometabolic imbalances and
respective changes in trace element status [1, 2]. Another
known link is at the level of metal-storage proteins, metal-
lothioneins, which bind different metals, thus acting in their
storage and detoxification [5–7].
Interactions of different trace elements with iron deter-
mine the relationship between changes in trace element
status in the organism and development of IDA. Increases
in content of antagonistic to iron trace elements, such as
cobalt, zinc, copper, chromium, and calcium, which impair
iron absorption or its physiological impact, can lead to
development of IDA. Deficiencies of synergistic to iron trace
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elements implicated in iron metabolism or processes of
haematopoiesis, such as copper, chromium, nickel, sodium,
and potassium, can contribute substantially to the aetiology
of IDA [4].
Only 35–55% of cases of IDA in children are solely due
to iron deficiency and others are associated with changes in
status of multiple trace elements.
In our study, we use serum trace element concentrations
as markers of trace element status in the organism.
Results published from different researchers on status of
trace elements in IDA are various and often conflicting.
Most of the researchers have discovered lower serum zinc
levels in subjects with IDA in comparison to nonanaemic
subjects [8–11], but others have not found significant dif-
ferences in serum zinc between IDA subjects and healthy
controls [12–14].
In studies on copper content in serum and blood, higher
[8–10, 12, 15] and lower levels [16, 17] as well as levels without
significant differences [13, 14] have been discoveredin subjects
with ID and anaemia in comparison to nonanaemic and
iron-adequate subjects. Both low and high serum copper
concentrations have been observed in a subset of anaemic
participants in a study of Knovich et al. [18].
Although chromium is considered synergistic to iron
[4] and some researchers have found lower concentrations
in blood of anaemic patients when compared to control
subjects [17], it is known as an antagonistic competition
between trivalent chromium and trivalent iron for binding to
apotransferrin [4, 19].On the basis of this interaction, Lukaski
et al. have suggested adverse effect of high-dose and long-
term chromium supplementation on iron metabolism and
status in adults [20].
Cobalt and nickel are essential trace elements with signifi-
cant impact on the processes of haematopoiesis—stimulation
of erythropoietin production and haemoglobin synthesis
[21]. Lower concentrations of nickel have been observed in
blood of anaemic children as compared to healthy controls
[17]. Higher concentrations of cobalt have been found in
blood at low body iron stores [2].
Our literature search shows that many researchers do not
explain changes in trace element status with mechanisms for
transport and storage.
The aim of the study is to determine trace element status,
aetiologic factors, and mechanisms for development of trace
elements deficiencies in children with IDA from 0 to 3 years
of age.
2. Clinical Contingent and Methods
Our investigation comprises 78 patients from 0 to 3 years of
age with clinical and laboratory signs of IDA. 30 children-
patients are of the University Hospital, Medical University,
Pleven, Bulgaria—I group, and 48 are patients of the Sumy
Regional Child’s Clinical Hospital, Sumy, Ukraine—II group.
Comparison group includes 25 healthy children at the same
age.
Anaemia was defined according to the criteria adopted by
the WHO. Haemoglobin level below 110 g/L and haematocrit
value below 0.33 l/l were used as diagnostic limits of anaemia.
In I group of patients, measures of iron status, especially
serum iron concentrations below 8.0 𝜇mol/L and transferrin
saturation (TS) below 16%, and low red cell indices were
used to identify that anaemia was due to ID [22]. Percent
TS was calculated as a ratio of serum iron and total iron-
binding capacity (TIBC)—serum iron/TIBC × 100. Serum
ferritin values were used as indicators for iron deficiency in
II group.
All children were enrolled in the study after informed
consent from their parents or guardians. Ethical approval was
obtained from the Institutional research ethics committees.
A parental questionnairewas provided to collect informa-
tion about feeding patterns.
Fasting venous blood samples were obtained for analysis
in the morning from all children into sterile tubes untreated
with heparin, EDTA, citrate, and so forth. After two hours
standing and centrifugation at 3500 rpm for 10 minutes,
blood serum was separated. The serum samples were put in
closed plastic laboratory vessels and stored at −18∘C until
trace element analysis.
In I group, serum content of trace elements iron, zinc,
copper, and chromium was determined spectrophotomet-
rically: ferrozine method [23] for serum iron and total
iron-binding capacity by COBAS INTEGRA 400 (Roche)
analyzer, spectrophotometric methods using GIESSE diag-
nostics (Italy) tests for serum zinc and AUDIT diagnostics
(Ireland) tests for serum copper, and spectrophotometric
method [24] with our modifications for serum chromium.
Serum concentrations of zinc, copper, and chromium were
determined by a spectrophotometer DR2800 (Hach Lange,
Germany).
The serum ferritin levels were determined by ELISAusing
a kit of reagents “UBI MAGIVEL FERRITIN” produced by
“United Biotech Inc.” (USA).
Haematological parameters, such as haemoglobin (Hb),
haematocrit (Ht), red blood cell (erythrocyte) count (RBC),
and the red cell indices, mean corpuscular volume (MCV),
mean corpuscular haemoglobin (VbX), mean corpuscular
haemoglobin concentration (VbXb), and red cell distribu-
tion width (RDW) were examined by analyzer MIKROS—
18 (ABX). The reticulocyte count was determined by micro-
scopic examination of a peripheral blood smear stained with
a supravital dye.
Serum trace element concentrations and haematological
parameters in I group of patients were compared to their
respective reference values indicated in Table 1.
In II group, the content of trace elements iron, zinc, cop-
per, cobalt, and nickel in blood serum and erythrocytes was
determined by atomic absorption spectrophotometry (AAS)
on a spectrophotometer C-115M1 (JSC “Selmi,” Ukraine) [25,
26]. All results from trace element analysis and investigated
haematological parameters in II group of patients were
compared to healthy controls. Content of trace elements in
blood serum and erythrocytes in comparison group was
determined by AAS.
Statistical data processing was performed using Excel
(Microsoft Corporation, Redmond, WA), Statgraphics
Plus (Manugistics, Rockville, MD), and Statistica 6.1
Anemia 3
Table 1: Haematological parameters and content of trace elements in blood serum of children with IDA.
Parameter Reference values I group with IDA
(𝑛 = 30)
II group with IDA
(𝑛 = 48)
Comparison group
(𝑛 = 25)Mean [27, 28] −2 SD [27, 28]
Haemoglobin (g/L) 120 105 90.23 ± 11.09 89.79 ± 1.23 119.15 ± 2.41
Haematocrit (L/L) 0.36 0.33 0.279 ± 0.029 0.301 ± 0.004 0.3442 ± 0.006
RBC (×1012 cells/L) 4.5 3.7 4.41 ± 0.65 3.58 ± 0.05 4.07 ± 0.12
Rtc (Ğ) 10 [28] — — 5.5 ± 0.87 7.86 ± 0.98
MCV (fL) 78 70 64.3 ± 9.87 74.66 ± 1.08 82.52 ± 1.17
MCH (pg) 27 23 20.93 ± 4.17 24.77 ± 0.39 29.82 ± 0.56
MCHC (g/L) 330 300 322.67 ± 18.16 323.47 ± 4.34 365.17 ± 3.6
RDW (%) 1.5–15 [29] 15.58 ± 1.56 — —
Iron (𝜇mol/L) 8.0–24.0 [30] 4.43 ± 1.21 9.23 ± 0.86 22.92 ± 1.83
Zinc (𝜇mol/L) 11.1–19.5 [5, 31] 11.22 ± 4.40 11.02 ± 1.79 17.96 ± 1.06
Copper (𝜇mol/L) 11.0–24.0 [6, 32] 11.81 ± 4.39 23.80 ± 0.76 16.50 ± 0.71
Chromium (𝜇mol/L) 0.95–9.5 [33] 0.83 ± 0.69 — —
Cobalt (𝜇mol/L × 10−3) 0.00–15.25 [34] — 5.74 ± 0.76 9.16 ± 0.61
Nickel (𝜇mol/L × 10−3) 1.70–10.22 [35] — 8.99 ± 0.868 14.35 ± 1.09
(StatSoft, USA). All values were expressed as mean ±
standard deviation (SD). Student’s 𝑡-test and Wilcoxon’s
test were used to evaluate differences between study
groups. Statistically significant differences were indicated by
𝑃 values < 0.05.
3. Results
Clinical manifestations of IDA in all children were demon-
strated by the presence of sideropenic and anaemic syn-
dromes.
Anaemic syndrome is manifested by such symptoms as
pallor of skin and mucous membranes, fatigue and faintness,
tachycardia, and systolic murmur. In a number of patients
apathy, drowsiness, or conversely, excessive irritability, and
emotional lability were observed due to decreased oxygen
delivery to the brain [36] and deficiency of iron which has
been shown to play a key role in brain functions [22].
Manifestations of hyposiderosis were due to deficiency of
iron-containing enzymes. Dryness of skin, changes in hair—
fragility, and dim color were observed; signs of angular stom-
atitis and atrophic glossitis were also found. Most children
suffered from loss of appetite. A number of patients had a
syndrome of muscular hypotonia. In some of the patients
with IDA increased size of the liver and spleen was observed
due to extramedullary haematopoiesis (Figures 1(a) and 1(b)).
Results of investigated clinical laboratory indicators in
patients with IDA, comparison group, and the respective
reference values are presented in Table 1.
All haematological parameters in anaemic children
exhibited changes in accordance with the presence of IDA.
Mean value of serum iron in I group of patients with IDA
was found to be lower than the reference values−4.43 ±
1.21 𝜇mol/L (Table 1, Figure 2(a)), and along with the low
transferrin saturation (TS)−6.23 ± 2.65%, indicated presence
of ID. In II group, serum ferritin content was found to be
9.42 ± 0.75 ng/mL which is significantly lower (𝑃 < 0.001)
in comparison to healthy controls −38.67 ± 4.18 ng/mL.
Mean values of serum zinc, copper, and chromium in I
group were all near the lower limits of the reference ranges
(Table 1, Figure 2(a)). In II group of patients with IDA, mean
serum iron, zinc, cobalt, and nickel concentrations were
found to be significantly lower, and mean serum copper level
was found to be significantly higher in comparison to their
respective controls (Table 1, Figure 2(b)) with reliability level
𝑃 < 0.05.
In I group, results for serum levels of zinc, copper, and
chromium (Table 1, Figure 2(a)) enable to divide examined
patients into two groups for each of the investigated trace
elements (Figure 3).
Patients with serum trace elements concentrations lower
than the reference values—serum zinc 7.29 ± 2.54 𝜇mol/L,
copper 8.6 ± 1.46 𝜇mol/L, and chromium 0.47 ± 0.14 𝜇mol/L,
are included in IA group. For each of the investigated trace
elements, the number of patients in this group constitutes
47% (𝑛 = 14), 57% (𝑛 = 17), and 73% (𝑛 = 22) of total number
of children with IDA in I group.
Patients with serum trace elements concentrations within
the reference values—serum zinc 14.65±2.21 𝜇mol/L, copper
16.0 ± 3.2 𝜇mol/L, and chromium 1.83 ± 0.61 𝜇mol/L, are
included in IB group. For each of the investigated trace
elements, the number of patients in this group includes 53%
(𝑛 = 16), 43% (𝑛 = 13), and 27% (𝑛 = 8) of total number of
participants with IDA in I group.
There are statistically significant differences between IA
and IB groups (𝑃 < 0.001).
Examination of trace element content in erythrocytes
showed significantly lower values for all investigated trace
elements in patients with IDA in comparison to control
subjects (Table 2).
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Figure 1: Clinical signs of IDA in I group (a) and II group (b).
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Figure 2: Serum concentrations of trace elements in I group (a) and II group (b) of children with IDA.
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Figure 3: Serum concentrations of zinc, copper, and chromium
among IA group and IB group of children with IDA.
4. Discussion
Under conditions of IDA, trace element status in the organ-
ism is largely influenced by metabolic interactions between
Table 2: Content of trace element in erythrocytes in children with
IDA and healthy controls.
Trace element content
(𝜇g/mg ash)
II group with IDA
(𝑛 = 48)
Comparison group
(𝑛 = 25)
Iron∗ 15.58 ± 1.13 31.56 ± 1.65
Zinc∗ 0.208 ± 0.013 0.260 ± 0.012
Copper∗ 0.176 ± 0.016 0.271 ± 0.039
Cobalt∗ 0.0316 ± 0.0023 0.0411 ± 0.0034
Nickel∗ 0.0330 ± 0.0023 0.0500 ± 0.0034
∗Reliability level 𝑃 < 0.05.
trace elements, some of which result from adaptation mech-
anisms for maximizing iron delivery for erythropoiesis [1, 2,
22]. Nutrition, physiologic features in different life periods,
and underlying pathological conditions also affect trace
element status. It has been shown that children in infancy and
early childhood are particularly susceptible to deficiencies
of iron and zinc, and copper deficiency occurs mainly in
infancy. This vulnerability is due to increased requirements
for rapid growth which are frequently not met by the diet
[6, 17, 22, 36, 37].
IDA often shows association with low serum zinc levels,
as well as zinc deficiency states [8–10]. In our study, obtained
values for serum zinc in patients with IDA were also lower in
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comparison to reference values and controls (Figures 2(b) and
3(a)). These changes in zinc status are frequently explained
by coexisting deficiencies of iron and zinc due to common
dietary sources of both micronutrients and decreasing their
intestinal absorption by the same dietary factors [9, 11].
Lower serum levels than the reference values were also
obtained for copper among most patients in I group (57%,
𝑛 = 17).
In our research, we found a number of factors associated
with low serum concentrations of zinc and copper in children
with IDA.
In 20%of childrenwith IDA from I group, therewas a his-
tory of preterm birth or low birth weight which are important
contributing factors for zinc and copper deficiencies because
of the inadequate prenatal stores and elevated requirements
for growth [6, 38].
Association between short duration of breast-feeding,
exclusive cow’s milk feeding and low serum levels of zinc
was observed in 57.14% of patients in IA group. Association
between the same dietary factors and low serum levels of
copper was observed in 64.7% of patients in IA group. This
relationship may probably be due to the lower zinc and
copper bioavailability from cow’s milk in comparison to
human milk and the low copper content of cow’s milk [5–
7, 38, 39].
Malabsorption due to cow’s milk protein-induced
enteropathy may be regarded as a factor for development
of micronutrient deficiencies in 10% of patients with IDA
[5, 6, 18, 37].
Low serum concentrations of zinc and copper in some of
the investigated children may be attributed to the inadequate
consumption of foods with high bioavailability of zinc and
copper—meat, poultry, and fish, which are important dietary
sources of zinc and copper in children’s diet [5, 15, 39, 40].
Other dietary factor is the early introduction and high intake
of flour-based foods containing the inhibitors of zinc and
copper absorption phytates [7, 17].These dietary factors were
observed in 78.6% of patients with low serum levels of zinc
and in 76.47% of patients with low serum levels of copper
from I group.
The proposed mechanisms explaining low serum zinc
and copper levels in some of the investigated children are
antagonistic interactions between zinc and copper within
the enterocyte [7]. Impaired intestinal absorption of zinc
is observed under conditions of high intake of copper
attributed to competitive antagonism between both metals
for absorption sites in the gastrointestinal tract [3, 5].
In relatively high dietary intake of zinc, production of
metal-binding proteinsmetallothioneins in intestinalmucosa
is induced.Asmetallothioneins have a greater affinity for cop-
per than zinc, this is followed by sequestration of high pro-
portion of dietary copper in a stable copper-metallothionein
complex in intestinal mucosal cells—“mucosal block” in cop-
per transport, reduction in copper absorption, and increased
copper excretion [5, 7].
Low serum concentrations of zinc and copper, which
we found in investigated children, may be considered as
contributing factors for IDA due to known synergistic
interactions of both trace elements with iron—participation
of zinc in haemoglobin synthesis and its essentiality in
erythropoiesis [7, 41], and implication of copper-containing
enzymes ceruloplasmin and hephaestin, ferrochelatase and
cytochrom-c oxidase in iron metabolism, formation of
haemoglobin, and mechanisms of hematopoiesis [4, 6, 7,
42]. Studies in animals and humans have found that copper
deficiency can lead to ID [1, 4] and IDA [6, 7, 43].
It is difficult to identify factors explaining relatively high
serum levels of zinc found in some patients with IDA from
IB group, as well as their relationship with development of
IDA. Some studies have shown that nutritional deficiency of
iron enhances the intestinal absorption of zinc suggesting the
divalent metal transporter 1 (DMT1) as a common absorptive
pathway for both metals and physiological basis for such an
interaction [44]. Although zinc is considered antagonistic to
iron [4] on the basis of absorptive competition, conflicting
results have been obtained in studies evaluating effect of zinc
on iron absorption, and DMT1 has been postulated as an
unlikely site for competitive antagonism [7].
Discovering significantly higher serum copper in II group
of patients with IDA in comparison to healthy controls and
relatively high serum copper in a part of IB group may be
considered as a consequence of adaptation mechanisms in
ID intended to maximize iron delivery for erythropoiesis [1].
There are data for upregulating the duodenal iron transporter
DMT1 which is also a physiologically relevant copper trans-
porter and theMenkes copper ATPase (MNKprotein, Atp7a)
on the basolateral membrane of enterocytes under low iron
conditions [1, 2, 13].
It has been shown that increased copper absorption
induced by ID might contribute to IDA [12] due to known
antagonistic competition between copper and iron at the level
of DMT1 [4, 8]. Moreover, higher serum copper concentra-
tions are related to high levels of serum ceruloplasmin which,
because of the antagonism with zinc, lowers zinc to copper
(Zn : Cu) ratio. This is known to increase hemolysis and
peroxidation of erythrocytes and thereby promotes anemia
[7, 43]. Therefore, higher serum levels of copper in II group
of patients and relatively high although in the reference range
serum levels of copper in IB group may be considered as an
important contributing factor for IDA.
In addition, imbalance of erythrocyte and serum copper
was observed in II groupof childrenwith IDAwith significant
increase of its concentration in the blood serum, but copper
deficiency in red blood cells (Table 2). It is known that
erythrocyte deficiency of copper impairs incorporation of
iron into the haem structure [43].
The serum concentrations of chromium were found to
be lower than the reference values in 73% of children with
IDA in I group. Other researchers [17] have also discovered
significantly lower concentrations of chromium in blood
of anaemic patients when compared to control subjects.
Chromium is considered synergistic to iron and its deficiency
can lead to ID [4]. For the rest 27% of patients with IDA
in I group, serum chromium concentrations within the
reference values were found. This is explained by the fact
that besides being synergistic, chromium can be antagonistic
to iron due to competition for binding to apotransferrin.
Significantly reduced uptake of iron by serum transferrin
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has been observed in the presence of chromium [4, 19].
Therefore, in these children, serum chromium levels found
may be associated with negative influence of chromium on
iron metabolism, thus contributing to the aetiology of IDA.
Both cobalt and nickel mean serum concentrations in
our study were found to be significantly lower in children
with IDA than healthy controls (𝑃 < 0.05). Cobalt and
nickel play important roles in the processes of erythropoiesis.
It has been shown that both metals stimulate erythropoi-
etin production by activation of the transcription factor
hypoxia-inducible factor 1𝛼 (HIF-1𝛼). Cobalt influencesDNA
synthesis accelerating maturation of erythroid stem cells
and stimulates haemoglobin synthesis [21, 45]. Nickel is
considered synergistic to iron by promoting its intestinal
absorption and nickel deficiency can lead to ID and anaemia
[4, 17, 46]. Therefore, deficiencies of both trace elements
might be a contributing factor for development of IDA in our
study.
However, it is difficult to identify the contribution factors
explaining these results because although serum levels of
cobalt and nickel were found to be lower than the control
subjects, they were within the reference values. It has been
shown that the intestinal absorption of iron, cobalt, and
nickel ismediated by a common transportmechanism,DMT1
[2, 47], which is known to be upregulated by ID [2, 13]. It
has been found, however, that transport capacity for cobalt
and nickel was lower than the iron because of a higher
binding constant and lower exchange rate for both metals
as compared with iron. This probably not only results in
suppressed duodenal uptake of iron but also explains lower
levels of cobalt and nickel whichwe observed in childrenwith
IDA [21].
We also found that dietary factors and malabsorption
may be regarded as associated with lower serum concentra-
tions of cobalt and nickel in our patients with IDA. Important
dietary sources of cobalt are animal tissues or products, such
as meat, eggs, and dairy products, which were found to be
scarce in the diet of the children with IDA. High dietary
intake of cow’s milk, frequently observed in children of
infancy and early childhood, and found as a common dietary
pattern in our patients with IDA, does not obligatory provide
sufficient intake of cobalt because of the known geochemical
cobalt deficiency. As cow’s milk has low nickel content and
contains factors inhibiting nickel absorption, cow’s milk-
based dietary patterns observed in our study may be a
possible reason for lower serum levels of nickel discovered.
Intestinal malabsorption, found in certain patients with IDA,
is also known as contributing to low cobalt and nickel content
in the organism [48–50].
5. Conclusion
Through the present study including investigation of trace
element status, we expand the aetiology of IDA. Data
obtained can be used for developing a diagnostic algorithm
for IDA.
Low serum trace element concentrations of zinc, copper,
cobalt, and nickel, mainly due to inadequate dietary intake,
malabsorption problems, and trace element interactions,
were found in both studied groups (I and II groups) of
children with IDA.
Profiles of trace elements iron and zinc in blood serum do
not differ in the two examined groups by the means of two
analytical methods applied. Increased serum concentrations
of copper in II group in comparison to control subjects are
probably due to metabolic changes resulting from adaptation
mechanisms in IDA.
Dietary insufficiencies of micronutrients, as well as low
concentrations of trace elements in blood serum, are com-
mon in children with IDA under 3 years of age. However,
mechanisms for metabolic interactions between trace ele-
ments based on transport and storage molecules are not
clearly investigated yet. Micronutrient deficiency in patients
with IDA can lead to the formation of so-called related
functional iron deficiency. In this case, it is considered that
molecular mechanisms provided by trace elements responsi-
ble for iron absorption and transport and further included in
haem structure are probably impaired.This could lead to low
efficiency of the monotherapy by iron supplements.
High prevalence of nutrition-related disorders in trace
element status under conditions of IDA indicates the
need to develop and implement appropriate interven-
tion strategies for prevention and control of micronutri-
ent deficiencies—supplementation, fortification, and dietary
diversification/modification.
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